Immunogen | Passivo Circulante



Current Liabilities Alterar Data
AbbVie USD 38.75B 4.31B 2024-12
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Amgen USD 23.01B 91M 2025-03
Astellas Pharma JPY 1.06T 90.95B 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Exelixis USD 399.1M 4.67M 2025-04
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
MacroGenics USD 55.53M 3.78M 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 29.16B 865M 2024-12



Immunogen Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.